Psychiatric Journals

Psychiatry

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bruce RD et al. – No dosage modification of BUP/NLX is required when co–administered with TPV/r. Though mechanistically unclear, it is likely that decreased plasma RTV levels while on BUP/NLX contributed substantially to the decrease in TPV levels. BUP/NLX and TPV/r should therefore be used cautiously to avoid decreased efficacy of TPV in patients taking these agents concomitantly.

Today in Substance Abuse...keeping you current

Examining why smokers do not want behavioral support with stopping smoking
Patient Education and Counselling, 11/23/09

Lung function testing influences the attitude toward smoking cessation
Nicotine & Tobacco Research, 11/23/09

The natural history of quitting smoking: findings from the International Tobacco Control (ITC) Four Country Survey
Addiction, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address